CorMedix (CRMD) Receivables - Net (2013 - 2025)

CorMedix (CRMD) has 12 years of Receivables - Net data on file, last reported at $171.2 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables - Net rose 231.5% year-over-year to $171.2 million; the trailing twelve-month figure through Dec 2025 stood at $171.2 million (up 231.5% YoY), and the FY2025 full-year result was $171.2 million, up 231.5% from the prior year.
• Receivables - Net grew to $171.2 million in Q4 2025, from $158.6 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $171.2 million in Q4 2025 to a low of $2975.0 in Q1 2022.
• A 4-year average of $45.2 million and a median of $17.4 million in 2024 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net sank 93.18% in 2022 and surged 20696.87% in 2025, its largest moves.
• Tracing CRMD's Receivables - Net over 4 years: stood at $45368.0 in 2021, then plunged by 93.44% to $2975.0 in 2022, then soared by 1736168.91% to $51.7 million in 2024, then jumped by 231.5% to $171.2 million in 2025.
• Business Quant data shows CRMD's Receivables - Net at $171.2 million in Q4 2025, $158.6 million in Q3 2025, and $42.9 million in Q2 2025.